Today: 29 April 2026
CoreWeave stock slides nearly 19% as $35 billion spending plan jolts investors (CRWV)
27 February 2026
2 mins read

CoreWeave stock slides nearly 19% as $35 billion spending plan jolts investors (CRWV)

New York, Feb 27, 2026, 12:03 EST — Regular session

  • CoreWeave dropped roughly 19% by midday, with shares under pressure after the company projected a significant spike in 2026 expenditures.
  • Management pointed to short-term margin pressure, with the company scrambling to ramp up AI data-center capacity.
  • Funding routes, progress on construction, and the U.S. inflation reading slated for March 13 are all in investors’ sights.

CoreWeave dropped roughly 19% to $79.09 by midday in New York, having hit a session low of $78.04. The stock had wrapped up Thursday at $97.63.

The AI cloud infrastructure company jolted the market with its forecast for 2026 capex: $30 billion to $35 billion, a figure that more than doubles its outlay for 2025. “Markets … are concerned about the long-term economics and how the company plans to fund the investment,” said Russ Mould, investment director at AJ Bell. Reuters

That’s important right now—CoreWeave operates in the priciest stretch of the AI supply chain, where snapping up business hinges on speed, but rising funding costs can cut into margins before you blink. Investors haven’t hesitated to hammer firms touting growth only to show up with fatter expenses.

Friday brought unwelcome news: U.S. producer prices climbed faster than economists anticipated in January. That readout fueled expectations the Federal Reserve won’t cut rates just yet—an outlook that keeps funding costs in focus for companies needing cash. Next up, January PCE inflation figures drop March 13.

CoreWeave logged $1.572 billion in revenue for the fourth quarter, while posting a net loss of $452 million and net interest expense totaling $388 million. Year-end revenue backlog came in at $66.8 billion, representing contracted revenue still to be recognized. Cash and cash equivalents totaled $3.127 billion at the close of 2025.

CEO Michael Intrator said the company opted “to build faster” in order to get more infrastructure online, but noted that “Q1 is going to be the low point” for margins. On the call, CFO Nitin Agrawal told analysts that current spending lines up with already signed customer contracts. D.A. Davidson’s Alexander Platt pointed out the stock has been hit for “either having too little capex or too much capex.” Reuters

On Thursday, CoreWeave filed an 8-K, tacking on the earnings release as an attachment.

JPMorgan trimmed its price target on CoreWeave to $90 from $110 on the back of valuation concerns but kept a Neutral rating. Stifel also took its target down, now at $110 from $120, maintaining a Hold. Both pointed to the margin miss and increased spending.

Still, the selloff spells out a risk investors can’t ignore. Should the company fail to ramp up capacity on schedule—or if tighter credit bites as rates remain elevated—that backlog supporting the spending plan might quickly flip from an asset into a delivery headache, stretching out the path to profitability.

Next up, investors are eyeing whether fresh data-center power and GPU capacity actually land as promised, plus any new word on financing plans for the 2026 expansion. The big macro event comes March 13, with January PCE inflation numbers out from the U.S.

Stock Market Today

  • Tuya (TUYA) Stock Analysis: Fair Pricing Amid Recent Pullback and Strong Long-Term Gains
    April 29, 2026, 12:05 PM EDT. Tuya (NYSE:TUYA) shares closed at $2.28, down 3.0% in one day and 6.2% over seven days, contrasting with a 3-year total shareholder return of 28.7%. The company reported $321.8 million in annual revenue and $57.9 million net income. Trading at a price-to-earnings (P/E) ratio of 24.1x, Tuya's valuation is slightly above its fair value estimate of 23.5x and peers' average of 21.7x, but below the broader U.S. Software industry average of 30.4x. This reflects investor confidence in its profitability and growth prospects, with earnings expected to grow nearly 10% annually. Risks include dependence on Chinese market demand and relatively rich valuation compared to peers. The stock trades just 0.9% below its intrinsic value according to discounted cash flow (DCF) estimates, suggesting near fair pricing.

Latest article

Mastercard Stock Jumps Before Earnings as Visa’s Big Beat Sends a Fresh Signal

Mastercard Stock Jumps Before Earnings as Visa’s Big Beat Sends a Fresh Signal

29 April 2026
Mastercard shares climbed 3.8% to $526.90 Wednesday after Visa beat profit estimates and raised its outlook, sending Visa shares up 8.7%. Mastercard reports first-quarter results Thursday. The company expanded its Start Path program this week to focus on business payments, with fintech Glass joining to work on public-sector procurement. Mastercard does not lend or issue cards, earning mainly from transaction fees.
GE HealthCare Technologies Inc. Stock Sinks as Tariffs and Chip Costs Force Profit Cut

GE HealthCare Technologies Inc. Stock Sinks as Tariffs and Chip Costs Force Profit Cut

29 April 2026
GE HealthCare cut its 2026 profit forecast Wednesday, citing higher chip, oil, and freight costs, as well as tariffs and a supplier issue. Shares fell nearly 13% to $59.75. First-quarter revenue rose 7.4% to $5.13 billion, but net income dropped to $389 million from $564 million a year earlier. The company also announced a reorganization, merging its Imaging and Advanced Visualization units.
Applied Materials (AMAT) Faces Fresh China Shock After U.S. Targets Hua Hong Shipments

Applied Materials (AMAT) Faces Fresh China Shock After U.S. Targets Hua Hong Shipments

29 April 2026
The U.S. Commerce Department ordered Applied Materials, Lam Research, and KLA to halt some chip-tool shipments to China’s Hua Hong, Reuters reported. The move targets shipments linked to facilities believed capable of advanced chip production. Applied reported $2.10 billion in China revenue last quarter, or 30% of its total. Shares in Applied, Lam, and KLA traded lower after the news.
UnitedHealth stock today: UNH rises on dividend return as Medicare Advantage rates near a key deadline
Previous Story

UnitedHealth stock today: UNH rises on dividend return as Medicare Advantage rates near a key deadline

Dow Jones today: Why the index is down more than 600 points on inflation and AI nerves
Next Story

Dow Jones today: Why the index is down more than 600 points on inflation and AI nerves

Go toTop